Discovery of a Potent, Selective, and Orally Bioavailable Acidic 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1) Inhibitor: Discovery of 2-[(3S)-1[5-(Cyclohexylcarbamoyl)-6-propylsulfanylpyridin-2-yl]-3-piperidyl]acetic Acid (AZD4017)

被引：52

作者：

Scott, James S. ^{[1
]}

Bowker, Suzanne S. ^{[1
]}

deschoolmeester, Joanne ^{[1
]}

Gerhardt, Stefan ^{[1
]}

Hargreaves, David ^{[1
]}

Kilgour, Elaine ^{[1
]}

Lloyd, Adele ^{[1
]}

Mayers, Rachel M. ^{[1
]}

McCoull, William ^{[1
]}

Newcombe, Nicholas J. ^{[1
]}

Ogg, Derek ^{[1
]}

Packer, Martin J. ^{[1
]}

Rees, Amanda ^{[1
]}

Revill, John ^{[1
]}

Schofield, Paul ^{[1
]}

Selmi, Nidhal ^{[1
]}

Swales, John G. ^{[1
]}

Whittamore, Paul R. O. ^{[1
]}

机构：

[1] AstraZeneca Mereside, Cardiovasc & Gastrointestinal Innovat Med Unit, Macclesfield SK10 4TG, Cheshire, England

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2012年 / 55卷 / 12期

关键词：

DIABETES-MELLITUS; METABOLIC SYNDROME; HYPERTENSION; 1-AMINOBENZOTRIAZOLE; CLEARANCE; CHEMISTRY; CORTISOL; MK-0916; OBESITY; LACKING;

D O I：

10.1021/jm300592r

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Inhibition of 11 beta-HSD1 is an attractive mechanism for the treatment of obesity and other elements of the metabolic syndrome. We report here the discovery of a nicotinic amide derived carboxylic acid class of inhibitors that has good potency, selectivity, and pharmacokinetic characteristics. Compound 11i (AZD4017) is an effective inhibitor of 11 beta-HSD1 in human adipocytes and exhibits good druglike properties and as a consequence was selected for clinical development.

引用

页码：5951 / 5964

页数：14

共 50 条

[31] Discovery of 2-(4-((1H-1,2,4-triazol-1-yl)methyl)-5-(4-bromophenyl)-1-(2-chlorophenyl)-1H-pyrazol-3-yl)-5-tert-butyl-1,3,4-thiadiazole (GCC2680) as a potent, selective and orally efficacious cannabinoid-1 receptor antagonist
Lee, Jinhwa
Seo, Hee Jeong
Lee, Suk Ho
Kim, Jeongmin
Jung, Myung Eun
Lee, Sung-Han
Song, Kwang-Seop
Lee, Junwon
Kang, Suk Youn
Kim, Min Ju
Kim, Mi-Soon
Son, Eun-Jung
Lee, MinWoo
Han, Ho-Kyun
BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (17) : 6377 - 6388
[32] Discovery of 2-hydroxy-N,N-dimethyl-3-{2-[[(R)-1-(5-methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobut-1-enylamino}benzamide (SCH 527123):: A potent, orally bioavailable CXCR2/CXCR1 receptor antagonist
Dwyer, Michael P.
Yu, Younong
Chao, Jianping
Aki, Cynthia
Chao, Jianhua
Biju, Purakkattle
Girijavallabhan, Viyyoor
Rindgen, Diane
Bond, Richard
Mayer-Ezel, Rosemary
Jakway, James
Hipkin, R. William
Fossetta, James
Gonsiorek, Waldemar
Bian, Hong
Fan, Xuedong
Terminelli, Carol
Fine, Jay
Lundell, Daniel
Merritt, J. Robert
Rokosz, Laura L.
Kaiser, Bernd
Li, Ge
Wang, Wei
Stauffer, Tara
Ozgur, Lynne
Baldwin, John
Taveras, Arthur G.
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (26) : 7603 - 7606
[33] (2S,4S)-1-[2-(1,1-Dimethyl-3-oxo-3-pyrrolidin-1-yl-propylamino)acetyl]-4-fluoro-pyrrolidine-2-carbonitrile: A potent, selective, and orally bioavailable dipeptide-derived inhibitor of dipeptidyl peptidase IV
Yeh, Teng-Kuang
Tsai, Ting-Yueh
Hsu, Tsu
Cheng, Jai-Hong
Chen, Xin
Song, Jen-Shin
Shy, Horng-Shing
Chiou, Mei-Chun
Chien, Chia-Hui
Tseng, Ya-Ju
Huang, Chung-Yu
Yeh, Kai-Chia
Huang, Yu-Lin
Huang, Chih-Hsiang
Huang, Yu-Wen
Wang, Min-Hsien
Tang, Hung-Kuan
Chao, Yu-Sheng
Chen, Chiung-Tong
Jiaang, Weir-Torn
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (12) : 3596 - 3600
[34] Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis
Ruminski, Peter G.
Massa, Mark
Strohbach, Joseph
Hanau, Cathleen E.
Schmidt, Michelle
Scholten, Jeffrey A.
Fletcher, Theresa R.
Hamper, Bruce C.
Carroll, Jeffery N.
Shieh, Huey S.
Caspers, Nicole
Collins, Brandon
Grapperhaus, Margaret
Palmquist, Katherine E.
Collins, Joe
Baldus, John E.
Hitchcock, Jeffrey
Kleine, H. Peter
Rogers, Michael D.
McDonald, Joseph
Munie, Grace E.
Messing, Dean M.
Portolan, Silvia
Whiteley, Laurence O.
Sunyer, Teresa
Schnute, Mark E.
JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (01) : 313 - 327
[35] Discovery of 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-(tert-butyl)pyridine-3-sulfonamide (CZC24758), as a potent, orally bioavailable and selective inhibitor of PI3K for the treatment of inflammatory disease
Sunose, Mihiro
Bell, Kathryn
Ellard, Katie
Bergamini, Giovanna
Neubauer, Gitte
Werner, Thilo
Ramsden, Nigel
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (14) : 4613 - 4618
[36] Discovery of 1-[3-(aminomethyl)phenyl]-N-[3-fluoro-2′- (methylsulfonyl)-[1,1′-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423), a highly potent, selective, and orally bioavailable inhibitor of blood coagulation factor Xa
Pinto, DJP
Orwat, MJ
Wang, SG
Fevig, JM
Quan, ML
Amparo, E
Cacciola, J
Rossi, KA
Alexander, RS
Smallwood, AM
Luettgen, JM
Liang, L
Aungst, BJ
Wright, MR
Knabb, RM
Wong, PC
Wexler, RR
Lam, PYS
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (04) : 566 - 578
[37] Discovery and characterization of 4-oxo-4-(5-(5-phenyl-1,2,4-oxadiazol-3-yl)indolin-1-yl)butanoic acids as potent and selective human S1P1 receptor agonists
Buzard, Daniel J.
Han, Sangdon
Thoresen, Lars
Moody, Jeanne
Kawasaki, Andrew
Sage, Carleton
Gao, Yinghong
Edwards, Jeffrey
Barden, Jeremy
Thatte, Jayant
Fu, Lisa
Solomon, Michelle
Gatlin, Joel
Le, Minh
Xing, Charles
Lezarda, Sheryl
Jones, Robert M.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
[38] 5-Chlorothiophene-2-carboxylic Acid [(S)-2-[2-Methyl-3-(2-oxopyrrolidin-1-yl)benzenesulfonylamino]-3-(4-methylpiperazin-1-yl)-3-oxopropyl]amide (SAR107375), a Selective and Potent Orally Active Dual Thrombin and Factor Xa Inhibitor
Meneyrol, Jerome
Follmann, Markus
Lassalle, Gilbert
Wehner, Volkmar
Barre, Guillaume
Rousseaux, Tristan
Altenburger, Jean-Michel
Petit, Frederic
Bocskei, Zsolt
Schreuder, Herman
Alet, Nathalie
Herault, Jean-Pascal
Millet, Laurence
Dol, Frederique
Florian, Peter
Schaeffer, Paul
Sadoun, Freddy
Klieber, Sylvie
Briot, Christophe
Bono, Francoise
Herbert, Jean-Marc
JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (23) : 9441 - 9456
[39] Discovery of N-[5-(6-Chloro-3-cyano-1-methyl-1H-indol-2-yl)-pyridin-3-ylmethyl]-ethanesulfonamide, a Cortisol-Sparing CYP11B2 Inhibitor that Lowers Aldosterone in Human Subjects
Papillon, Julien P. N.
Lou, Changgang
Singh, Alok K.
Adams, Christopher M.
Ksander, Gary M.
Beil, Michael E.
Chen, Wei
Leung-Chu, Jennifer
Fu, Fumin
Gan, Lu
Hu, Chii-Whei
Jeng, Arco Y.
LaSala, Daniel
Liang, Guiqing
Rigel, Dean F.
Russell, Kerry S.
Vest, John A.
Watson, Catherine
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (23) : 9382 - 9394
[40] Discovery of a potent, selective, and orally bioavailable c-Met inhibitor:: 1-(2-Hydroxy-2-methylpropyl)-N-(5-(7-methoxyquinolin-4-yloxy)pyridin-2-yl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamide (AMG 458)
Liu, Longbin
Siegmund, Aaron
Xi, Ning
Kaplan-Lefko, Paula
Rex, Karen
Cheti, April
Lin, Jasmine
Moriguchi, Jodi
Berry, Loren
Huang, Liyue
Teffera, Yohannes
Yang, Yajing
Zhang, Yihong
Bellon, Steven F.
Lee, Matthew
Shimanovich, Roman
Bak, Annette
Dominguez, Celia
Norman, Mark H.
Harmange, Jean-Christophe
Dussault, Isabelle
Kimt, Tae-Seong
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (13) : 3688 - 3691

← 1 2 3 4 5 →